Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Is something truly better than nothing? The impact of bystander CPR quality on survival in out-of-hospital cardiac arrest.

Resuscitation·2026

Same author

Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure.

Asian biomedicine : research, reviews and news·2026

Same author

Tailoring inter-core distance of clustered SPIONs using silica spacers for enhanced magnetic particle imaging (MPI).

Nanoscale·2026

Same author

A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation.

Clinical pharmacology and therapeutics·2026

Same author

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Clinical pharmacology and therapeutics·2026

Same author

Accelerating Generic Long-Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access.

Clinical pharmacology and therapeutics·2026

Search research articles

Related Experiment Video

Updated: May 14, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Nanomedicines for HIV therapy.

Marco Siccardi¹, Philip Martin, Tom O McDonald

¹Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK. siccardi@liverpool.ac.uk

Therapeutic Delivery

|January 25, 2013

Summary

Nanomedicine offers improved HIV treatment by enhancing drug delivery and targeting. This approach optimizes nanoparticle design for better antiretroviral effectiveness and safety.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Related Experiment Videos

Last Updated: May 14, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Area of Science:

Pharmacology and Nanotechnology
Drug Delivery Systems
HIV Therapeutics

Background:

Variability in how patients respond to HIV treatments is often due to differences in how the drugs are processed by the body (pharmacokinetics).
Traditional HIV drug formulations may not achieve optimal drug concentrations at the target site, leading to varied treatment outcomes.
Nanomedicine presents a promising alternative to conventional drug delivery methods for antiretroviral agents.

Purpose of the Study:

To explore the potential of nanomedicine to improve antiretroviral drug delivery and overcome pharmacokinetic variability in HIV treatment.
To investigate the development of optimized nanoformulations for enhanced bioavailability and targeted delivery of HIV medications.
To apply a closed-loop design process for continuous optimization of nanoparticle characteristics.

Main Methods:

Development of nanoformulations including solid drug nanoparticles, polymer-based carriers, and nanoemulsions.
Utilizing a closed-loop design process for nanoparticle optimization.
Employing experimental pharmacological data from in vitro and in vivo models to guide nanoparticle development.

Main Results:

Nanomedicine formulations show potential for increased bioavailability of antiretroviral drugs.
Targeted delivery to the site of action can be achieved with nanomedicine approaches.
Continuous optimization based on pharmacological data allows for refinement of nanoparticle disposition, activity, and safety.

Conclusions:

Nanomedicine holds significant promise for improving the efficacy and safety of HIV treatments.
Optimized nanoformulations can address pharmacokinetic variability and enhance antiretroviral deployment.
The closed-loop design process facilitates the development of advanced nanomedicine-based HIV therapies.